≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Migraine without aura, drug-induced

EFO Endpoint Browser PheWeb

G6_MIGRAINE_NO_AURA_ADVERSE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — G43.0#

1 out of 7 registries used, show all original rules.

435

4. Check minimum number of events

None

435

5. Include endpoints

None

435

6. Filter based on genotype QC (FinnGen only)

435

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
G43
Name in latin
Hemicrania sine aura

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 435 348 87
Unadjusted period prevalence (%) 0.10 0.12 0.04
Median age at first event (years) 31.29 32.91 24.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
399
Matched controls
3989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
+∞
323.0
399
129
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
10.9
94.0
223
416
N02CC03
ATC
zolmitriptan; nasal, oral
10.2
53.7
115
152
N02CC04
ATC
rizatriptan; oral
9.1
50.2
115
169
G43.9
ICD-10 Finland
Migraine, unspecified
9.4
48.4
108
151
N02CX04
ATC
NA
24.8
39.6
56
26
C07AA05
ATC
propranolol; systemic
4.1
32.7
165
590
N02CC06
ATC
eletriptan; oral
8.5
27.4
62
84
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
25.6
137
494
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
5.5
25.6
81
175
M01AG02
ATC
tolfenamic acid; oral, rectal
3.8
25.5
132
464
M01AE02
ATC
naproxen; oral, rectal
3.2
24.5
293
1856
N02CC02
ATC
naratriptan; oral
12.5
24.3
44
39
N02CC05
ATC
almotriptan; oral
7.1
23.6
60
97
N06AA09
ATC
amitriptyline; systemic
5.1
22.1
75
174
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.8
22.1
80
199
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
24.8
21.6
30
13
N03AX11
ATC
topiramate; oral
9.6
21.2
44
51
N05AB04
ATC
prochlorperazine; systemic, rectal
13.2
19.0
33
27
M01AE03
ATC
ketoprofen; systemic, rectal
2.7
18.6
175
890
G43
ICD-10 Finland
Migraine
5.4
17.8
56
118
R51.80
ICD-10 Finland
Headache
3.2
17.1
105
403
N03AG01
ATC
valproic acid; systemic, rectal
4.9
17.0
58
134
G43.3
ICD-10 Finland
Complicated migraine
10.4
16.5
32
33
N02CC07
ATC
frovatriptan; oral
4.9
16.2
55
126
C07AB02
ATC
metoprolol; systemic
3.3
15.4
88
318
R51
ICD-10 Finland
Headache
4.6
15.2
54
130
G44.2
ICD-10 Finland
Tension-type headache
3.1
14.7
92
352
G43.8
ICD-10 Finland
Other migraine
13.2
14.6
25
20
C07AB07
ATC
bisoprolol; oral
2.4
14.3
159
856
C09CA06
ATC
candesartan; oral
2.7
13.3
105
464
N05BA01
ATC
diazepam; systemic, rectal
3.2
13.1
76
274
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
13.0
179
1056
M03BX02
ATC
tizanidine; oral
2.2
12.4
280
2047
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
11.2
204
1336
3007
Kela drug reimbursment
Erenumab and fremanezumab
9.6
11.1
22
24
N89
ICPC
Migraine
5.0
11.0
35
75
N02CD01
ATC
erenumab; parenteral
11.7
10.7
19
17
M03BC01
ATC
orphenadrine (citrate); systemic
2.2
10.2
122
662
C08DA01
ATC
verapamil; systemic
5.6
9.9
28
53
A02BC01
ATC
omeprazole; systemic
2.2
9.2
110
592
N02AX02
ATC
tramadol; systemic, rectal
2.0
9.1
157
980
N03AX12
ATC
gabapentin; oral
2.5
8.9
75
338
N02BE01
ATC
paracetamol; systemic, rectal
2.2
8.2
342
2913
R518
ICD-10 Finland
NA
17.6
8.1
12
7
G43.2
ICD-10 Finland
Status migrainosus
34.1
8.1
10
*
A02BC02
ATC
pantoprazole; systemic
1.8
7.9
248
1881
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
7.9
107
601
N06AX11
ATC
mirtazapine; oral
1.9
7.8
135
835
A02BA02
ATC
ranitidine; systemic
2.2
7.0
79
407
UJF32
NOMESCO Finland
Coloscopy
2.0
7.0
94
523
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
7.0
114
685
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
6.9
39
139
A02BC03
ATC
lansoprazole; oral
1.9
6.8
115
700
H02AB06
ATC
prednisolone; systemic
1.8
6.8
179
1261
N06AB04
ATC
citalopram; systemic
2.0
6.7
100
581
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
6.5
110
666
A02BC05
ATC
esomeprazole; systemic
1.7
6.3
162
1122
N02CD03
ATC
fremanezumab; systemic
9.5
6.3
12
13
G44.8
ICD-10 Finland
Other specified headache syndromes
9.5
6.3
12
13
J01FA10
ATC
azithromycin; systemic
1.7
6.3
260
2076
N03AX16
ATC
pregabalin; oral
1.9
6.1
93
543
R42
ICD-10 Finland
Dizziness and giddiness
2.1
6.1
75
404
J01AA02
ATC
doxycycline; systemic
1.8
6.1
298
2488
A03DA02
ATC
pitofenone and analgesics; systemic
6.9
6.1
14
21

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019150) Specific gravity of Urine by Refractometry
141
776
2.21
12.54
4.7
3.2
kg/l
1.0
1.0
1.32
13
101
(3011397) Hemoglobin [Presence] in Urine by Test strip
134
785
2.02
9.74
4.5
3.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
149
925
1.93
9.06
4.9
3.2
estimate
0.0
0.0
0.40
48
336
(3018418) pH of Serum or Plasma
145
909
1.89
8.46
4.3
3.6
ph
7.4
7.4
0.25
29
164
(3044889) 12 lead EKG panel
295
2303
1.87
8.41
3.9
3.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
322
2631
1.86
7.39
5.5
3.7
mm/h
9.6
9.7
0.09
309
2460
(3009261) Glucose [Presence] in Urine by Test strip
239
1798
1.73
7.23
4.2
3.1
estimate
0.0
0.0
0.80
51
321
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
55
257
2.31
6.99
2.6
2.3
ml/min/173m2
73.2
72.7
0.03
31
96
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
47
209
2.40
6.68
1.6
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
235
1784
1.69
6.67
5.0
4.2
estimate
0.0
0.0
0.00
49
336
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
152
1026
1.74
6.66
3.6
2.3
u/l
54.4
55.6
0.20
143
958
(3013826) Glucose [Moles/volume] in Serum or Plasma
245
1882
1.69
6.64
5.2
4.2
mmol/l
6.2
6.4
0.42
234
1719
(3035350) Ketones [Presence] in Urine by Test strip
234
1776
1.69
6.64
4.3
3.0
estimate
0.0
0.0
0.00
48
330
(3020891) Body temperature
27
91
3.10
6.50
3.4
4.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
48
223
2.30
6.18
1.4
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
92
549
1.86
6.03
1.3
1.4
titre
667.4
432.1
0.72
19
107
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
183
1329
1.65
5.96
5.5
5.5
mmol/l
1.2
1.2
2.28
171
1215
(3019060) Gas panel - Arterial blood
35
143
2.57
5.95
3.1
8.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
87
515
1.86
5.84
2.3
2.0
ug/g
71.9
92.1
0.54
74
398
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
313
2617
1.70
5.72
8.9
6.7
u/l
72.1
75.7
0.98
302
2470
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
370
1.96
5.53
6.2
5.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
53
269
2.10
5.50
4.4
9.2
mmol/l
1.0
1.4
0.26
38
214
(40761535) Cells panel - Urine sediment
49
242
2.15
5.46
4.6
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
173
1263
1.61
5.38
5.0
4.0
g/l
36.9
36.7
0.21
159
1186
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
341
2945
1.73
5.23
5.1
4.2
pmol/l
14.5
14.5
0.07
322
2755
(3013650) Neutrophils [#/volume] in Blood by Automated count
254
2042
1.59
5.18
10.7
8.7
e9/l
4.0
3.9
0.35
238
1799
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
133
920
1.64
5.09
2.1
2.0
u/l
112.4
178.8
1.57
128
876
(3001604) Monocytes [#/volume] in Blood
223
1752
1.56
4.94
7.9
5.5
e9/l
0.5
0.5
0.19
210
1550
(3006315) Basophils [#/volume] in Blood
224
1762
1.56
4.93
7.8
5.5
e9/l
0.0
0.0
1.00
210
1554
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
194
1478
1.56
4.92
6.5
6.2
mmol/l
1.2
1.2
1.79
165
1259
(3001122) Ferritin [Mass/volume] in Serum or Plasma
226
1787
1.55
4.82
3.2
2.7
ug/l
81.7
81.1
0.03
219
1674
(40760892) CBC W Ordered Manual Differential panel - Blood
128
888
1.63
4.81
5.7
4.3
—
—
—
0
0
(3015736) pH of Urine
185
1404
1.55
4.72
3.9
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
103
680
1.67
4.68
1.4
1.3
u/ml
13.3
11.9
0.07
54
284
(3018677) aPTT in Platelet poor plasma by Coagulation assay
69
407
1.83
4.65
2.5
2.0
s
29.0
29.4
0.29
69
397
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
60
340
1.89
4.58
1.5
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
112
763
1.63
4.49
2.4
1.9
mg/l
2.8
3.0
0.71
103
650
(3019225) pH of Specimen
9
290
0.30
4.40
3.6
4.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
35
3.80
4.39
2.7
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
122
853
1.60
4.39
6.9
6.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
181
1387
1.52
4.32
4.5
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
226
1821
1.50
4.21
8.0
5.5
e9/l
2.0
2.0
0.00
213
1642
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
215
1716
1.50
4.19
6.0
5.4
umol/l
9.5
9.9
0.35
206
1632
(3013139) Helicobacter pylori Ag [Presence] in Stool
47
253
1.96
4.18
1.1
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
16
52
3.16
4.12
3.1
2.7
mmol/l
25.7
25.2
0.13
16
45
(3013115) Eosinophils [#/volume] in Blood
226
1831
1.49
4.04
8.0
5.8
e9/l
0.2
0.2
0.74
212
1641
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
96
647
1.62
3.98
3.4
2.9
ng/l
508.5
790.6
0.93
86
527
(3007853) Bacteria identified in Skin by Aerobe culture
63
379
1.77
3.97
1.9
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
93
624
1.62
3.93
2.8
2.2
e6/l
5.1
8.1
1.01
88
553
(42870588) Differential panel, method unspecified - Blood
148
1105
1.51
3.91
7.2
5.3
—
—
—
0
0
(4010399)
43
230
1.96
3.90
1.6
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
438
1.71
3.85
1.9
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
148
1109
1.51
3.83
4.1
2.9
ng/l
11.5
21.3
3.97
83
598
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
154
1171
1.49
3.69
1.9
1.8
pmol/l
99.4
99.0
0.03
81
584
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
307
1.79
3.50
1.9
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
49
285
1.81
3.46
3.2
2.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
99
695
1.55
3.43
1.4
1.3
iu/ml
27.0
31.9
0.27
37
228
(3015377) Calcium [Moles/volume] in Serum or Plasma
142
1079
1.47
3.36
2.5
3.0
mmol/l
2.3
2.4
1.16
128
967
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
65
2.68
3.34
2.0
3.4
—
768.6
—
0
7
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
68
440
1.65
3.30
1.9
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
185
1482
1.43
3.30
2.4
2.2
nmol/l
75.4
75.5
0.02
176
1359
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
113
823
1.50
3.29
2.5
1.7
mg/l
0.9
0.8
0.24
89
609
(40767503) Oxygen content in Capillary blood by calculation
13
43
3.09
3.27
3.2
1.7
%
17.9
16.0
—
8
17
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
78
2.50
3.26
2.2
2.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
269
2308
1.43
3.26
4.7
3.9
e6/l
750.4
571.6
—
7
28
(4034850)
24
110
2.25
3.25
13.9
8.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
126
2.13
3.09
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
126
2.13
3.09
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
123
923
1.46
3.07
1.5
1.3
u/ml
1.1
2.2
0.76
58
260
(3014051) Protein [Presence] in Urine by Test strip
19
81
2.41
3.03
2.5
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
51
2.80
3.01
3.4
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
113
838
1.47
2.99
3.0
2.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
26
129
2.08
2.92
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
130
2.06
2.87
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
395
3698
1.74
2.87
16.3
10.6
mg/l
18.0
20.1
0.77
321
2835
(3020961) Endomysium IgA Ab [Titer] in Serum
36
203
1.84
2.83
1.1
1.1
—
195.0
—
0
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
125
2.06
2.76
3.5
13.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
145
1143
1.40
2.72
4.0
3.2
e6/l
80.9
51.3
0.25
108
752
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
85
606
1.50
2.72
1.7
1.6
pmol/l
152631988.9
35955496.8
0.52
76
534
(40761511) CBC panel - Blood by Automated count
412
3915
1.99
2.71
13.5
9.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
137
1073
1.40
2.66
10.3
5.8
inr
1.1
1.1
0.30
58
352
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
57
373
1.61
2.66
2.6
2.1
%
22.9
24.1
0.24
43
324
(3030467) Casts [#/volume] in Urine by Automated count
111
838
1.44
2.65
3.3
2.6
e6/l
0.2
0.4
1.44
94
619
(3002582) Erythrocytes [#/volume] in Urine
120
919
1.42
2.65
3.5
2.7
e6/l
15.8
68.2
1.96
100
687
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
48
302
1.66
2.61
1.9
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
70
483
1.54
2.60
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
50
2.65
2.55
1.6
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
137
1080
1.39
2.55
3.8
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
121
935
1.41
2.53
1.4
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
373
3466
1.53
2.52
3.9
3.8
mmol/l
5.7
5.7
0.07
361
3233
(3023368) Bacteria identified in Blood by Culture
96
713
1.44
2.49
4.6
3.7
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
21
3.86
2.47
1.1
1.7
umol/l
9.0
10.8
—
8
21
(3039000) Anion gap in Blood
13
51
2.60
2.46
1.7
16.6
mmol/l
12.1
10.6
0.60
13
46
(3018572) Chloride [Moles/volume] in Blood
13
52
2.55
2.38
1.7
16.3
mmol/l
105.5
105.4
0.04
13
47
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
76
545
1.48
2.36
3.6
3.2
ng/l
234.2
332.3
0.15
46
344
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
153
1243
1.36
2.33
3.9
3.0
u/l
30.5
29.4
0.13
145
1186
(3011288) Drugs identified in Urine by Screen method
28
156
1.85
2.31
5.0
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
367
3414
1.48
2.31
5.8
4.8
mu/l
1.7
2.1
0.59
349
3212
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
18
3.93
2.26
1.6
1.1
miu/ml
1344.6
1642.9
—
7
18
(3023323) Follitropin [Units/volume] in Serum or Plasma
45
291
1.61
2.22
1.3
1.3
iu/l
20.5
28.1
1.08
39
244
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
9
5.60
2.22
3.8
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
105
809
1.39
2.21
1.7
1.4
g/l
2.3
2.1
0.67
78
513
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
121
956
1.37
2.19
1.7
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
33
198
1.72
2.16
5.2
7.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
19
3.73
2.16
1.7
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
30
3.04
2.16
2.2
1.5
%
91.8
91.5
—
9
30
(3016879) Cocaine [Presence] in Urine
35
214
1.69
2.14
3.0
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
294
1.59
2.14
3.9
3.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
348
3220
1.40
2.12
19.4
13.0
%
13.5
13.5
0.02
342
3168
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
37
2.74
2.11
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
35
215
1.68
2.11
1.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
56
0.00
2.08
0.0
2.1
—
1.3
—
0
56
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
10
5.04
2.07
1.6
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
10
5.04
2.07
1.6
2.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
38
2.67
2.02
2.4
1.5
%
71.7
57.0
—
10
38
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
70
2.18
2.00
1.5
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
63
452
1.46
1.96
1.9
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
32
196
1.68
1.96
1.8
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
51
0.00
1.90
0.0
2.2
—
7.4
—
0
51
(3027315) Oxygen [Partial pressure] in Blood
12
52
2.34
1.89
4.7
1.6
kpa
9.1
9.3
0.19
12
52
(3019309) Folate [Moles/volume] in Red Blood Cells
62
450
1.44
1.82
1.7
1.6
nmol/l
1356.5
1183.3
0.94
51
341
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
407
3906
1.65
1.82
11.9
8.8
u/l
26.1
25.8
0.13
402
3791
(3027944) Amphetamines [Presence] in Urine
36
233
1.59
1.80
1.9
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
66
486
1.42
1.80
2.8
2.4
e6/l
0.6
1.0
0.83
45
255
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
29
2.79
1.80
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
29
2.79
1.80
1.3
1.7
—
—
—
0
0
(44790047)
8
29
2.79
1.80
1.6
1.4
—
—
—
0
0
(44790048)
8
29
2.79
1.80
1.6
1.4
—
—
—
0
0
(44790049)
8
29
2.79
1.80
1.6
1.4
—
—
—
0
0
(44806118)
8
29
2.79
1.80
1.6
1.4
—
—
—
0
0
(4062490)
10
41
2.47
1.76
1.9
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
27
163
1.70
1.76
2.1
2.5
e9/l
77.3
74.3
0.19
21
117
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
316
2911
1.31
1.76
3.4
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
156
1.71
1.73
2.2
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
96
1.91
1.73
1.5
10.4
%
2.2
1.6
0.89
18
90
(3000764) Benzodiazepines [Presence] in Urine
36
236
1.57
1.71
2.9
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
36
237
1.57
1.69
2.9
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
18
97
1.89
1.68
1.3
1.3
—
31.0
—
0
10
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
31
2.61
1.66
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
31
2.61
1.66
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
31
2.61
1.66
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
33
214
1.59
1.65
2.7
2.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
183
1.63
1.62
3.2
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
14
3.60
1.62
4.4
1.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
32
2.53
1.60
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
32
2.53
1.60
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
32
2.53
1.60
1.1
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
46
324
1.47
1.59
2.6
2.5
u/l
28.8
32.0
0.42
36
275
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
341
3190
1.32
1.59
4.7
4.6
mmol/mol
37.7
38.4
1.10
327
3010
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
20
3.03
1.58
1.7
1.2
%
114.2
118.0
—
6
15
(3022096) Basophils/100 leukocytes in Blood
182
1583
1.26
1.55
7.5
5.6
%
0.7
0.7
0.22
175
1486
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
29
186
1.60
1.53
1.7
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
15
3.36
1.52
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
109
1.78
1.49
1.4
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
38
2.40
1.46
1.2
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
28
2.52
1.45
1.0
1.0
u/ml
—
0.1
—
0
6
(3013290) Carbon dioxide [Partial pressure] in Blood
11
52
2.14
1.45
4.5
1.6
kpa
4.9
5.0
0.29
11
52
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
142
1.65
1.41
1.7
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
28
182
1.58
1.41
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
60
455
1.37
1.40
2.8
2.5
e6/l
3.7
3.5
0.05
36
225
(3022145) Colonoscopy Study observation
52
385
1.40
1.40
1.3
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
180
1578
1.24
1.40
11.7
7.7
e9/l
0.0
0.0
0.20
152
1300
(3012544) pH of Venous blood
33
224
1.51
1.38
2.4
3.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
82
1.86
1.37
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
23
2.63
1.37
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
68
1.94
1.34
1.3
1.3
u/ml
1.0
2.8
—
6
17
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
68
1.94
1.34
1.6
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
42
2.17
1.34
1.7
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
66
512
1.34
1.34
2.3
2.4
mmol/l
2.4
2.4
0.49
52
454
(3008898) HLA-B27 [Presence]
30
201
1.53
1.34
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
98
1.76
1.33
1.7
1.4
ug/g
356.2
323.8
0.24
12
55
(3021788) Differential panel - Synovial fluid
9
43
2.12
1.31
1.2
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
113
947
1.26
1.29
2.8
2.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
34
2.38
1.29
1.6
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
236
1.48
1.29
3.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
35
2.31
1.27
1.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
171
1504
1.23
1.26
1.9
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
246
1.46
1.26
1.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
185
1641
1.22
1.26
7.8
5.5
%
2.9
2.8
0.44
176
1541
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
36
2.24
1.25
1.4
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
63
1.93
1.24
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
519
1.32
1.23
1.6
1.6
—
—
—
0
0
(4306422)
11
56
1.99
1.23
1.1
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
56
1.99
1.23
1.3
1.4
—
30.2
—
0
5
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
78
1.82
1.22
1.4
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
37
2.18
1.22
1.6
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
37
265
1.43
1.21
6.9
4.4
%
1.2
0.9
0.15
11
78
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
109
1.68
1.20
1.3
1.6
iu/ml
0.0
0.1
—
5
12
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
52
397
1.35
1.18
2.7
2.1
umol/l
8.0
7.9
0.01
46
332
(3019069) Monocytes/100 leukocytes in Blood
185
1650
1.21
1.17
8.3
5.7
%
8.2
8.1
0.09
179
1560
(3002032) Base excess in Venous blood by calculation
31
216
1.47
1.17
2.5
3.0
mmol/l
1.6
2.1
0.28
23
174
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
126
1.62
1.16
2.8
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
64
506
1.31
1.16
1.8
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
20
2.52
1.15
2.2
1.5
%
11.8
10.1
—
5
20
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
16
95
1.71
1.15
1.6
10.6
%
1.0
0.9
0.16
16
90
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
65
1.87
1.14
1.3
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
351
0.67
1.14
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
101
848
1.25
1.14
1.6
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
95
792
1.26
1.14
2.2
2.4
umol/l
302.7
5673.3
3.43
83
701
(3024928) Oxygen saturation in Venous blood
10
51
1.98
1.12
2.1
2.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
267
2473
1.21
1.11
4.5
3.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
189
1696
1.20
1.11
7.4
5.3
%
55.5
56.2
0.40
180
1604
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
120
1.61
1.10
1.3
1.3
—
22.6
—
0
8
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
21
2.40
1.09
2.4
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
25
171
1.49
1.05
4.5
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
187
1686
1.19
1.02
4.4
3.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
147
1.52
1.02
6.8
5.1
mmol/l
24.5
25.3
0.42
22
147
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
83
1.71
1.02
1.2
1.3
—
1.1
—
0
6
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
68
1.79
1.01
1.7
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.3
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
23
2.19
0.98
1.4
1.1
iu/ml
86.0
158.2
—
5
23
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
29
0.00
0.98
0.0
2.0
—
4.0
—
0
29
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
29
0.00
0.98
0.0
2.0
—
105.5
—
0
29
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
29
0.00
0.98
0.0
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
36
1.96
0.97
1.4
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
192
1.43
0.95
3.1
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
37
1.91
0.94
1.1
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
52
1.75
0.93
1.4
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.92
1.5
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
94
1.62
0.91
5.7
2.4
g/l
3.6
3.2
—
9
80
(3002030) Lymphocytes/100 leukocytes in Blood
188
1709
1.18
0.91
7.8
5.5
%
29.6
29.7
0.02
181
1616
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
72
1.69
0.86
1.2
1.3
u/ml
1.7
8.7
—
6
25
(3050129) First trimester maternal screen panel - Serum or Plasma
18
261
0.68
0.85
1.4
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
51
410
1.28
0.84
1.5
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
45
356
1.29
0.84
1.3
1.2
iu/ml
125.9
162.4
0.34
26
153
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
382
0.74
0.80
1.7
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
41
323
1.30
0.80
1.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
98
1.55
0.79
5.7
2.3
g/l
3.7
3.7
—
9
79
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
98
1.55
0.79
5.7
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
98
1.55
0.79
5.7
2.3
g/l
7.5
7.4
—
9
84
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
48
1.68
0.79
1.4
2.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
48
1.68
0.79
2.1
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
26
0.00
0.78
0.0
1.7
—
14.8
—
0
9
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3000492) Spirometry study
47
380
1.27
0.76
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
67
1.66
0.75
5.5
2.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
67
1.66
0.75
4.0
3.7
%
59.5
58.1
0.22
11
67
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
75
1.62
0.75
1.9
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
477
0.78
0.75
1.5
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
54
1.68
0.75
5.4
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
24
2.10
0.74
3.8
3.8
u/ml
390.8
652.5
—
5
24
(3021960) Folate [Moles/volume] in Serum or Plasma
76
650
1.21
0.74
1.6
1.5
nmol/l
18.9
21.9
1.27
69
562
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
125
1.46
0.74
1.4
1.9
iu/l
2.1
5.6
—
5
44
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
92
1.54
0.73
1.5
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
56
1.62
0.72
2.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
143
1.42
0.71
2.4
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
41
1.72
0.70
1.6
1.2
nmol/l
—
—
—
0
0
(3026782) Osmolality of Urine
68
579
1.21
0.70
2.7
2.1
mosm/kgh2o
521.1
543.4
0.34
62
495
(3025159) Blasts/100 leukocytes in Blood
31
240
1.31
0.69
8.0
4.6
%
0.0
0.2
—
7
59
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
103
911
1.17
0.69
1.8
1.6
mmol/l
1.5
1.4
0.67
88
797
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
42
1.68
0.68
1.6
1.2
u/l
19.0
17.2
—
7
37
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
111
1.46
0.67
1.3
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
16
111
1.46
0.67
1.3
1.3
—
3.2
—
0
14
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
86
1.53
0.66
1.6
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
365
3543
1.19
0.64
14.2
11.4
%
41.0
40.2
2.12
288
2868
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
378
3681
1.21
0.63
4.5
4.2
mmol/l
2.9
2.9
0.07
363
3454
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
147
1.38
0.63
1.7
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
71
1.56
0.62
2.0
1.2
u/ml
102.7
117.9
—
5
14
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
165
1.35
0.61
1.3
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
64
1.58
0.59
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
41
338
1.24
0.58
7.6
5.0
mmol/l
1.0
1.0
0.08
41
316
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.3
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
141
1.36
0.57
2.2
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
31
248
1.27
0.57
8.0
4.6
%
0.3
0.1
—
8
67
(3003327) Ova and parasites identified in Stool by Light microscopy
20
150
1.35
0.57
1.4
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
65
1.55
0.56
4.3
3.3
e9/l
3.4
4.4
—
10
65
(3026389) Candida sp identified in Specimen by Organism specific culture
6
37
1.63
0.55
1.2
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
72
816
0.86
0.54
1.9
2.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
241
1.26
0.54
2.6
2.4
u/l
1183.8
2695.4
0.52
12
113
(3002179) Metamyelocytes/100 leukocytes in Blood
30
242
1.26
0.52
7.1
4.4
%
0.3
0.6
—
8
54
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
16
213
0.74
0.51
1.7
2.0
mg/l
6.7
2.4
0.70
11
146
(3028707) Methadone [Presence] in Urine by Screen method
14
101
1.40
0.50
5.0
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
102
925
1.13
0.50
3.3
3.0
mmol/l
8.3
7.8
0.47
96
799
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
110
1.38
0.49
1.8
1.6
—
253.3
—
0
6
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
233
0.76
0.48
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
177
0.73
0.48
2.2
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
47
1.50
0.47
1.6
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
68
1.48
0.47
1.1
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
351
3421
1.13
0.46
13.7
9.4
ml/min/173m2
89.9
89.4
0.17
291
2772
(4268621)
7
51
1.38
0.44
2.1
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
341
1.19
0.44
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
113
1040
1.12
0.44
3.3
2.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
218
0.77
0.43
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
218
0.77
0.43
1.5
1.4
—
—
—
0
0
(4094501)
11
78
1.42
0.43
1.0
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
17
131
1.31
0.42
1.1
1.5
—
4.1
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
217
0.77
0.42
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
217
0.77
0.42
1.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
32
1.57
0.42
3.2
2.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
57
1.41
0.42
1.5
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
57
1.41
0.42
1.0
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
370
3624
1.14
0.41
4.0
3.8
mmol/l
1.5
1.5
2.46
360
3414
(3051651) Icteric interference index of Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
29.0
—
0
16
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
709.1
—
0
12
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
32.6
—
0
11
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
228.7
—
0
12
(3044640) Blood type and Crossmatch panel - Blood
116
1076
1.11
0.39
1.9
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
107
1155
0.90
0.39
1.8
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
371
3639
1.13
0.38
4.2
3.8
mmol/l
4.9
4.9
0.09
362
3434
(40768793) Breast Pathology biopsy report
8
116
0.68
0.37
1.1
1.3
—
—
—
0
0
(3013512) EKG study
74
809
0.90
0.34
3.6
3.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
44
1.37
0.34
5.3
2.7
u/ml
14.2
42.9
—
6
44
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
100
1.31
0.34
4.5
2.8
mg/l
12.1
10.0
0.55
13
93
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
87
0.69
0.33
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.7
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
46
1.31
0.33
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
74
1.36
0.32
1.4
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
6
47
1.28
0.32
1.8
1.3
mu/l
296.4
56.6
—
6
42
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
356
3493
1.11
0.32
3.6
3.4
mmol/l
1.3
1.2
0.75
344
3277
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
107
0.74
0.29
1.1
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
18
150
1.21
0.27
2.6
3.6
ph
7.5
7.4
—
7
16
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
16
192
0.83
0.26
2.1
2.2
ug/l
0.7
0.7
—
10
86
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
76
1.19
0.24
2.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
18
152
1.19
0.24
2.6
3.6
kpa
5.1
5.2
0.22
18
141
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
62
669
0.91
0.24
2.1
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
136
0.80
0.23
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
191
1.16
0.22
1.3
1.3
miu/ml
329.5
261.4
—
10
96
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
135
0.81
0.22
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
40
439
0.90
0.21
1.3
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
548
1.09
0.21
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
4.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
19
219
0.86
0.21
5.0
3.4
ng/l
131.8
73.4
0.85
19
194
(3052851) Hemolysis interference index of Serum or Plasma
10
80
1.26
0.20
2.4
2.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
14
0.00
0.20
0.0
6.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
49
1.23
0.20
6.7
5.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
260
1.12
0.20
2.4
3.6
%
23.9
22.7
0.17
11
82
(46235355) HIV 1 and 2 tests - Meaningful Use set
107
1022
1.06
0.19
2.2
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
53
1.13
0.18
3.0
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
62
660
0.93
0.18
2.2
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
67
0.74
0.17
5.6
5.8
umol/l
413.4
363.7
—
5
61
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
139
1.16
0.16
1.8
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
270
2653
1.05
0.16
3.0
2.9
u/l
40.6
38.7
0.20
257
2523
(3049717) Cytology report of Urine Cyto stain
6
77
0.78
0.15
1.8
1.9
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
80
0.75
0.15
4.2
1.2
ug/l
2.8
2.8
—
6
73
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
78
1.16
0.15
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
35
323
1.09
0.15
1.9
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
70
736
0.94
0.15
2.3
2.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
181
0.88
0.14
1.6
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
141
1.14
0.14
1.5
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
100
0.80
0.13
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
100
0.80
0.13
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
541
1.06
0.13
1.6
1.8
%
1.2
1.4
0.88
49
491
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
178
0.90
0.11
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
177
0.90
0.10
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
147
1500
0.97
0.09
2.5
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
58
1.03
0.08
1.0
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
67
1.05
0.08
1.1
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
74
0.81
0.07
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
77
1.04
0.07
1.5
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
89
1.13
0.07
2.2
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
93
0.86
0.07
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
152
0.92
0.06
1.6
1.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
11
102
1.08
0.03
1.5
1.3
mg/l
696.2
419.9
0.57
11
97
(21494755) Public health laboratory ask at order entry panel
56
571
0.98
0.03
1.3
1.3
—
—
—
0
0
(1002224) Polysomnography panel
22
211
1.04
0.03
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
268
0.97
0.02
2.7
3.7
ug/l
4.7
7.6
0.52
18
214
(3012516) Albumin [Mass/volume] in Urine
77
777
0.99
0.01
3.3
3.2
mg/l
832.1
322.2
0.27
52
480
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
94
1.07
0.01
1.5
1.3
mmol/l
3.8
3.8
—
10
87
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
145
1.04
0.00
1.1
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
17
165
1.03
0.00
4.2
2.4
u/l
38.5
40.3
0.16
17
149
(4035726)
28
275
1.02
0.00
1.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
81
814
0.99
0.00
3.9
3.9
mg/mmol
5.6
9.6
0.61
50
490
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
69
0.87
0.00
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
69
0.87
0.00
1.2
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
8.5
—
25.6
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.5
—
4.8
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
16.2
—
0
6
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
6.7
—
0
9
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
59
0.85
0.00
1.8
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
80
1.00
0.00
4.0
2.4
mg/l
1.5
1.4
—
8
74
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
56
0.89
0.00
1.6
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: G6_MIGRAINE_NO_AURA_ADVERSE – Migraine without aura, drug-induced

GWS hits: 1

This endpoint is excluded (not available in FinRegistry).